Hygeia Holdings Inc. news

HYG said five members of its board tendered their resignations at the request of the San Diego company, which said it intends to find replacement directors "with broad business and drug development experience." HYG's Hygeia Pharmaceuticals subsidiary is developing human monoclonal antibodies for cancer. ...